Synthesis and biological activity
Research Guide

Multicellular organisms feature three MAPK subfamilies—ERK, JNK, and p38—that control physiological processes through a phosphorelay system of sequential protein kinase phosphorylations. Johnson and Lapadat (2002) characterized these pathways in 'Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases'. They regulate a vast array of cellular functions via activation cascades.

Multicomponent reactions with isocyanides differ from two-component reactions and support pharmaceutical library preparation. Dömling and Ugi (2000) detailed their use in 'Multicomponent Reactions with Isocyanides' for low-molecular-weight druglike compounds. These reactions have become standard in organic synthesis for drug discovery.

U0126 is 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene, identified as an inhibitor of AP-1 transactivation. Favata et al. (1998) showed in 'Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase' that it inhibits promoters with AP-1 elements without affecting those lacking them. It targets mitogen-activated protein kinase kinase activity.

Molecular docking predicts ligand-target interactions to identify therapeutic compounds and structure-activity relationships. Ferreira et al. (2015) reviewed its strategies in 'Molecular Docking and Structure-Based Drug Design Strategies' for drug discovery programs. Pinzi and Rastelli (2019) noted in 'Molecular Docking: Shifting Paradigms in Drug Discovery' its role without experimental structures.

Combinatorial libraries are designed using knowledge-based approaches to mimic known drug databases. Ghose et al. (1998) characterized this in 'A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1.', aiding automation in synthesis and screening. It addresses expanding protein targets from genomics.

Tools like Syntheseus and ASKCOS enable retrosynthetic planning and feasible route prediction. REINVENT4 supports de novo design and optimization via reinforcement learning. Syndirella generates synthetically tractable elaborations from fragment screens.